Artiva Biotherapeutics, Stock Forecast - 20 Period Moving Average

ARTV Stock   10.40  0.22  2.07%   
The 20 Period Moving Average forecasted value of Artiva Biotherapeutics, Common on the next trading day is expected to be 11.65 with a mean absolute deviation of 1.35 and the sum of the absolute errors of 55.27. Artiva Stock Forecast is based on your current time horizon.
  
Receivables Turnover is likely to climb to 20.00 in 2024. Fixed Asset Turnover is likely to climb to 1.43 in 2024. Common Stock Shares Outstanding is likely to climb to about 12.4 M in 2024.
A commonly used 20-period moving average forecast model for Artiva Biotherapeutics, Common is based on a synthetically constructed Artiva Biotherapeutics,daily price series in which the value for a trading day is replaced by the mean of that value and the values for 20 of preceding and succeeding time periods. This model is best suited for price series data that changes over time.

Artiva Biotherapeutics, 20 Period Moving Average Price Forecast For the 19th of December

Given 90 days horizon, the 20 Period Moving Average forecasted value of Artiva Biotherapeutics, Common on the next trading day is expected to be 11.65 with a mean absolute deviation of 1.35, mean absolute percentage error of 2.94, and the sum of the absolute errors of 55.27.
Please note that although there have been many attempts to predict Artiva Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Artiva Biotherapeutics,'s next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Artiva Biotherapeutics, Stock Forecast Pattern

Backtest Artiva Biotherapeutics,Artiva Biotherapeutics, Price PredictionBuy or Sell Advice 

Artiva Biotherapeutics, Forecasted Value

In the context of forecasting Artiva Biotherapeutics,'s Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Artiva Biotherapeutics,'s downside and upside margins for the forecasting period are 5.06 and 18.24, respectively. We have considered Artiva Biotherapeutics,'s daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
10.40
11.65
Expected Value
18.24
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Artiva Biotherapeutics, stock data series using in forecasting. Note that when a statistical model is used to represent Artiva Biotherapeutics, stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria82.4316
BiasArithmetic mean of the errors 0.6564
MADMean absolute deviation1.348
MAPEMean absolute percentage error0.1208
SAESum of the absolute errors55.27
The eieght-period moving average method has an advantage over other forecasting models in that it does smooth out peaks and valleys in a set of daily observations. Artiva Biotherapeutics, 20-period moving average forecast can only be used reliably to predict one or two periods into the future.

Predictive Modules for Artiva Biotherapeutics,

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Artiva Biotherapeutics,. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Artiva Biotherapeutics,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
3.7810.3716.96
Details
Intrinsic
Valuation
LowRealHigh
6.3712.9619.55
Details
5 Analysts
Consensus
LowTargetHigh
19.3421.2523.59
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.65-0.65-0.65
Details

Other Forecasting Options for Artiva Biotherapeutics,

For every potential investor in Artiva, whether a beginner or expert, Artiva Biotherapeutics,'s price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Artiva Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Artiva. Basic forecasting techniques help filter out the noise by identifying Artiva Biotherapeutics,'s price trends.

Artiva Biotherapeutics, Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Artiva Biotherapeutics, stock to make a market-neutral strategy. Peer analysis of Artiva Biotherapeutics, could also be used in its relative valuation, which is a method of valuing Artiva Biotherapeutics, by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Artiva Biotherapeutics, Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Artiva Biotherapeutics,'s price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Artiva Biotherapeutics,'s current price.

Artiva Biotherapeutics, Market Strength Events

Market strength indicators help investors to evaluate how Artiva Biotherapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Artiva Biotherapeutics, shares will generate the highest return on investment. By undertsting and applying Artiva Biotherapeutics, stock market strength indicators, traders can identify Artiva Biotherapeutics, Common entry and exit signals to maximize returns.

Artiva Biotherapeutics, Risk Indicators

The analysis of Artiva Biotherapeutics,'s basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Artiva Biotherapeutics,'s investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting artiva stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Artiva Stock Analysis

When running Artiva Biotherapeutics,'s price analysis, check to measure Artiva Biotherapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artiva Biotherapeutics, is operating at the current time. Most of Artiva Biotherapeutics,'s value examination focuses on studying past and present price action to predict the probability of Artiva Biotherapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artiva Biotherapeutics,'s price. Additionally, you may evaluate how the addition of Artiva Biotherapeutics, to your portfolios can decrease your overall portfolio volatility.